AC
LXRX icon

Amici Capital’s Lexicon Pharmaceuticals LXRX Stock Holding History

Amici Capital’s Portfolio LXRX Stock Details LXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-12,515
Closed -$134K – 112
2015
Q3 		$134K Hold
12,515
– – 0.01% 137
2015
Q2 		$101K Hold
12,515
– – ﹤0.01% 130
2015
Q1 		$83K Buy
+12,515
New +$85.5K ﹤0.01% 125

Other funds holding LXRX

AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
UL
Ulys LLC New York $25.4M AUM 201.03% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BM
Bridger Management New York $150M AUM 17.71% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Amici Capital's LXRX Position: Q4 2015 in Review

Amici Capital sold out of Lexicon Pharmaceuticals (LXRX) in Q4 2015, closing a stake of 12,515 shares — an estimated $134K sold.

Amici Capital first reported a position in LXRX in Q1 2015 and held it in 3 quarters. The position peaked at $134K in Q3 2015. 118 funds tracked by Wall St. Rank hold LXRX as of Q4 2015.

  • Amici Capital reported no remaining Lexicon Pharmaceuticals position as of Q4 2015 after selling out during the quarter.
  • Amici Capital sold 12,515 Lexicon Pharmaceuticals shares in Q4 2015, an estimated $134K.
  • Amici Capital first reported a position in Lexicon Pharmaceuticals in Q1 2015 and held it in 3 quarters.
  • Amici Capital's Lexicon Pharmaceuticals position peaked at $134K in Q3 2015.
  • 118 funds tracked by Wall St. Rank held Lexicon Pharmaceuticals as of Q4 2015.

Based on Amici Capital's 13F filing for Q4 2015, filed 16 Feb 2016.